Tempest Therapeutics, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
MRKMerck & Co., Inc. 1.82%80.940.7%$1591.61m
JNJJohnson & Johnson 0.07%163.980.7%$1030.91m
PFEPfizer Inc. 1.81%42.850.9%$940.80m
ABBVAbbVie, Inc. 0.90%108.421.9%$679.65m
BMYBristol-Myers Squibb Co. 1.06%58.201.0%$660.20m
LLYEli Lilly & Co. 0.65%243.881.1%$611.01m
AZNAstraZeneca Plc 0.94%60.741.0%$367.50m
NVSNovartis AG 1.71%84.570.2%$177.02m
GSKGlaxoSmithKline Plc 0.92%39.530.2%$162.25m
AVIRAtea Pharmaceuticals, Inc. -2.75%13.440.3%$118.52m
RGENRepligen Corp. 2.43%269.046.8%$118.43m
VTRSViatris, Inc. 2.99%13.980.0%$92.74m
NVONovo Nordisk A/S -0.09%104.560.1%$91.61m
EDSAEdesa Biotech, Inc. -0.73%8.160.0%$73.55m
SNYSanofi 2.56%49.290.2%$65.07m

Company Profile

Tempest Therapeutics, Inc.is a clinical-stage biotechnology company. It develops small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. The company is headquartered in South San Francisco, CA.